Search results for "Ash"

showing 10 items of 1718 documents

Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers

2016

Background: Adult-onset Still's disease (AOSD) is rare inflammatory disease of unknown etiology that usually affects young adults. The more common clinical manifestations are spiking fevers, arthritis, evanescent rash, elevated liver enzymes, lymphadenopathy, hepatosplenomegaly, and serositis. The multi-visceral involvement of the disease and the different complications, such as macrophage activation syndrome, may strongly decrease the life expectancy of AOSD patients. Methods: This study aimed to identify the positive and negative features correlated with the outcome of patients. A retrospective analysis of AOSD patients prospectively admitted to three rheumatologic centers was performed t…

AdultMale0301 basic medicinemedicine.medical_specialtyPrognosiHepatosplenomegalyArthritisDiseaseAdult-onset Still's diseaseYoung Adult03 medical and health sciencesSystemic score0302 clinical medicineRetrospective StudieInternal medicinemedicineHumansYoung adultRetrospective StudiesAdult-onset Still’s diseaseMedicine(all)030203 arthritis & rheumatologyPrognostic factorbusiness.industryMedicine (all)BiomarkerGeneral MedicineMiddle AgedPrognosismedicine.diseaseRashSurgerySettore MED/16 - Reumatologia030104 developmental biologyMacrophage activation syndromeMacrophage activation syndromeEtiologyAdult-onset Still’s disease; Macrophage activation syndrome; Prognostic factor; Systemic scoreFemalemedicine.symptombusinessStill's Disease Adult-OnsetSerositisBiomarkersHumanResearch ArticleBMC Medicine
researchProduct

Influence of alcohol in mouthwashes containing triclosan and zinc: an experimental gingivitis study

2005

Objectives: An experimental gingivitis model was used to analyse the influence of alcohol in mouthwashes containing 0.15% triclosan and zinc chloride on the formation of supragingival plaque, the development of gingivitis and the appearance of adverse events. Material and Methods: Using a double-blind crossover design, 30 subjects underwent two consecutive experimental phases with two 0.15% triclosan and zinc chloride mouthwashes, differentiated mainly by their excipient (hydroalcoholic or aqueous). In each phase, the subjects discontinued all oral hygiene measures and were treated solely with the randomly assigned experimental mouthwash for 21 days. Each experimental phase was preceded by …

AdultMaleAdolescentDental PlaqueMouthwashesDentistryAlcoholDental plaqueOral hygieneGingivitischemistry.chemical_compoundstomatognathic systemmedicineHumansAdverse effectEthanolbusiness.industrymedicine.diseaseGingivitisCrossover studyTriclosanTriclosanZincchemistryPeriodonticsItchingFemalemedicine.symptomEpidemiologic MethodsbusinessJournal of Clinical Periodontology
researchProduct

The role of stress and self-efficacy in somatic and psychological symptoms during the climacteric period - Is there a specific association?

2019

Abstract Objectives To investigate the influence and specificity of sociodemographic and psychological factors on the perception of symptoms associated with menopause. Study design Data are based on a nationwide cross-sectional survey study in Germany. A representative sample of 1350 females aged 14–95 years was examined. Sociodemographic factors, perceived stress, and self-efficacy were assessed. Women were divided into three age groups (young women ≤ 44 years; perimenopausal women 45–60 years; older women ≥ 61 years), and the Menopause Rating Scale (MRS) was used over the entire life span. Main outcome measures Total score on the Menopause Rating Scale (MRS) and hot flushes/sweating asses…

AdultMaleAdolescentPsychological interventionSweatingGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesYoung Adult0302 clinical medicineRating scaleNegatively associatedGermanySurveys and QuestionnairesMedicineHumans030212 general & internal medicineAssociation (psychology)AgedClimactericSelf-efficacyAged 80 and over030219 obstetrics & reproductive medicinebusiness.industryObstetrics and GynecologySurvey researchMiddle Agedmedicine.diseaseSelf EfficacyMenopauseCross-Sectional StudiesHot FlashesFemaleClimactericbusinessStress PsychologicalDemographyMaturitas
researchProduct

Clinical evaluation of antiseptic mouth rinses to reduce salivary load of SARS-CoV-2

2021

AbstractMost public health measures to contain the COVID-19 pandemic are based on preventing the pathogen spread, and the use of oral antiseptics has been proposed as a strategy to reduce transmission risk. The aim of this manuscript is to test the efficacy of mouthwashes to reduce salivary viral load in vivo. This is a multi-centre, blinded, parallel-group, placebo-controlled randomised clinical trial that tests the effect of four mouthwashes (cetylpyridinium chloride, chlorhexidine, povidone-iodine and hydrogen peroxide) in SARS-CoV-2 salivary load measured by qPCR at baseline and 30, 60 and 120 min after the mouthrinse. A fifth group of patients used distilled water mouthrinse as a contr…

AdultMaleAdolescentScienceMouthwashesArticleMalalties transmissibles PrevencióYoung AdultDouble-Blind Methodstomatognathic systemHumansChildSalivaAgedMultidisciplinarySARS-CoV-2QRInfant NewbornCOVID-19InfantMiddle AgedViral LoadPlacebo EffectVirusViral infectionChild PreschoolRandomized controlled trialsAnti-Infective Agents LocalMedicineFemale
researchProduct

Microbiological effects of an antiseptic mouthrinse in irradiated cancer patients

2010

Objective: To assess the microbiological effects of an antiseptic, non-alcohol based mouth-rinse containing chlorhexidine and cetylpyridinium chloride, in patients undergoing radiation therapy for head-and-neck cancer. Study Design: This was a parallel, double-blind, prospective, randomized clinical trial, including patients irradiated as part of the therapy of head-and-neck cancer, aged 18-75, with at least 10 teeth, and willing to sign an informed consent. Cancer patients were randomly assigned to one of the two treatments (test mouth-rinse or a placebo). Three visits were scheduled (baseline, 14 and 28 days). Microbiological findings were evaluated in tongue, mucosa and subgingival sampl…

AdultMaleAdolescentmedicine.drug_classmedicine.medical_treatmentMouthwashesDentistryCetylpyridiniumPlacebolaw.inventionYoung AdultAntisepticRandomized controlled trialDouble-Blind MethodlawTongueMedicineHumansProspective StudiesProspective cohort studyGeneral DentistryAgedMouthbusiness.industryChlorhexidineChlorhexidineCancerMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Radiation therapymedicine.anatomical_structureOtorhinolaryngologyHead and Neck NeoplasmsUNESCO::CIENCIAS MÉDICASAnti-Infective Agents LocalSurgeryFemalebusinessmedicine.drug
researchProduct

Driving habits and risk factors for traffic accidents among sleep apnea patients - a European multi-centre cohort study

2014

Obstructive sleep apnea is associated with increased motor vehicle accident risk, and improved detection of patients at risk is of importance. The present study addresses potential risk factors in the European Sleep Apnea Database and includes patients with suspected obstructive sleep apnea [n = 8476, age 51.5 (12.5) years, body mass index 31.0 (6.6) kg m(-2) , 82.4% driver's licence holders]. Driving distance (km year(-1) ), driver's licence type, sleep apnea severity, sleepiness and comorbidities were assessed. Previously validated risk factors for accident history: Epworth Sleepiness Scale ≥16; habitual sleep time ≤5 h; use of hypnotics; and driving ≥15 000 km year(-1) were analysed acro…

AdultMaleAutomobile DrivingPediatricsmedicine.medical_specialtyAdolescentDatabases FactualCognitive NeurosciencePoison controlSettore MED/10 - Malattie Dell'Apparato RespiratorioCohort StudiesYoung AdultBehavioral NeuroscienceRisk FactorsPrevalencedriving exposure hypersomnia motor vehicle crash registry sleepy driving traffic riskHumansMedicineAttentionRisk factorAgedAged 80 and overSleep Apnea Obstructivebusiness.industryEpworth Sleepiness ScaleAccidents TrafficSleep apneaApneaGeneral MedicineMiddle Agedmedicine.diseaseObesityEuropeObstructive sleep apneaFemaleMedical emergencymedicine.symptomSleepbusinessCohort studyJournal of Sleep Research
researchProduct

Efficacy of mometasone furoate microemulsion in the treatment of erosive-ulcerative oral lichen planus: pilot study

2004

Background:  Oral lichen planus (OLP) is a frequent immunological chronic disease, having different clinical forms: asymptomatic and symptomatic. Symptomatic OLP has been palliated with topical corticosteroids with different levels of efficacy and safety. The purpose of this pilot phase II clinical trial was to determine the efficacy of mometasone furoate microemulsion upon the symptoms and signs of erosive-ulcerative OLP. Methods:  Forty-nine patients with clinical and histologically confirmed erosive-ulcerative OLP were enrolled in this study (36 women and 13 men). Their average age was 56.4 years (from 28 to 78). The treatment consisted of 0.1% mometasone furoate microemulsion mouthwash …

AdultMaleCancer Researchmedicine.medical_specialtyErythemamedicine.drug_classAdministration TopicalAnti-Inflammatory AgentsMouthwashesMometasone furoatePilot ProjectsAsymptomaticPathology and Forensic Medicinestomatognathic systemHumansMedicineAdverse effectGlucocorticoidsPregnadienediolsAgedbusiness.industryMometasoneMiddle Agedmedicine.diseaseDermatologyClinical trialstomatognathic diseasesOtorhinolaryngologyPeriodonticsCorticosteroidEmulsionsFemaleOral lichen planusOral Surgerymedicine.symptombusinessMometasone FuroateLichen Planus Oralmedicine.drugJournal of Oral Pathology and Medicine
researchProduct

Phase I Pharmacokinetic and Pharmacodynamic Dose-Escalation Study of RG7160 (GA201), the First Glycoengineered Monoclonal Antibody Against the Epider…

2011

Purpose We conducted a phase I dose-escalation study to characterize the safety, efficacy, pharmacokinetic (PK), and pharmacodynamic properties of RG7160 (GA201), a humanized and glycoengineered immunoglobulin G1 anti–epidermal growth factor receptor (EGFR) monoclonal antibody with enhanced antibody-dependent cell-mediated cytotoxicity. Patients and Methods Seventy-five patients with advanced EGFR-positive solid tumors received RG7160 (50 to 1,400 mg) administered every week, every 2 weeks, or every 3 weeks. Dose escalation followed a three-plus-three trial design. Results No maximum-tolerated dose was reached for any dosing schedule. Common adverse events (AEs) included rash (80% of patien…

AdultMaleCancer Researchmedicine.medical_specialtyMaximum Tolerated DoseAntineoplastic AgentsPharmacologyAntibodies Monoclonal HumanizedGastroenterologyHypomagnesemiaCohort StudiesYoung AdultPharmacokineticsGrowth factor receptorNeoplasmsInternal medicineHumansMedicineDosingEpidermal growth factor receptorAdverse effectAgedGlycoproteinsAged 80 and overDose-Response Relationship Drugbiologybusiness.industryMiddle Agedmedicine.diseaseRashErbB ReceptorsOncologyPharmacodynamicsbiology.proteinFemalemedicine.symptombusinessJournal of Clinical Oncology
researchProduct

A phase I dose-escalation study of the immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumours.

2012

Abstract Background EMD 521873 (Selectikine), an immunocytokine comprising a DNA-targeting antibody, aimed at tumour necrosis, fused with a genetically modified interleukin-2 (IL-2) moiety, was investigated in this first-in-human phase I study. Methods Patients had metastatic or locally advanced solid tumours failing previous standard therapy. Selectikine was administered as a 1-hour intravenous infusion on 3 consecutive days, every 3weeks. A subgroup of patients also received 300mg/m 2 cyclophosphamide on day 1 of each cycle. Escalating doses of Selectikine were investigated with the primary objective of determining the maximum tolerated dose (MTD). Results Thirty-nine patients were treate…

AdultMaleCancer Researchmedicine.medical_specialtyNecrosisCyclophosphamideMaximum Tolerated DoseLymphocyteRecombinant Fusion ProteinsSelectikineAntineoplastic AgentsPharmacologyGastroenterologyEMD 521873Young AdultPhase IDose-escalationInternal medicineNeoplasmsmedicineHumansAgedbiologyDose-Response Relationship Drugbusiness.industryEosinophilMiddle AgedRashAdvanced solid tumoursmedicine.anatomical_structureOncologyToxicitybiology.proteinInterleukin-2SelectikineFemalemedicine.symptomAntibodybusinessmedicine.drugEuropean journal of cancer (Oxford, England : 1990)
researchProduct

Chlorhexidine alcohol base mouthrinse versus Chlorhexidine formaldehyde base mouthrinse efficacy on plaque control: Double blind, randomized clinical…

2011

Background: Chlorhexidine is well known for its antiplaque effect. However, the mouthrinse based chlorhexidine antiplaque efficiency may vary according to the formulation of the final product. The aim of the present study was to compare anti-plaque effectiveness of two commercial mouthrinses: 0.12 % Chlorhexidine alcohol base (CLX-A) versus a diluted 0.1% Chlorhexidine non-alcohol base with 0.1% of Formaldehyde (CLX-F). Material and Methods: the study was a seven day randomized, double-blind, placebo-controlled trial including 30 volunteers. At the start, all participants received a dental prophylaxis. Over 7 days experimental non-brushing period, during which subjects abstained from all fo…

AdultMaleDental PlaqueMouthwashesFormaldehydeDentistryOdontologíaAlcoholPlaceboOral hygienePlaque controllaw.inventionDouble blindYoung Adultchemistry.chemical_compoundDouble-Blind MethodRandomized controlled triallawFormaldehydeHumansMedicineGeneral Dentistrybusiness.industryChlorhexidineChlorhexidineClinical and Experimental dentistry:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludOtorhinolaryngologychemistryUNESCO::CIENCIAS MÉDICASFemaleResearch-ArticleSurgerybusinessDisinfectantsmedicine.drugMedicina Oral Patología Oral y Cirugia Bucal
researchProduct